IL6 and cardiovascular disorder: The release of these fatty acids, coupled with some inflammatory cytokines production like tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), instigates systemic inflammation and the onset of metabolic disorders like cardiovascular disease and type 2 diabetes3–5.